All Stories

Sequel Med Tech connects twiist insulin pump to Abbott's CGM ahead of market debut

Greenlighted for people ages 6 and older with Type 1 diabetes, Sequel’s twiist system is slated to begin its commercial launch by the end of June.

Mar 19, 2025 - 11:50
 0
Sequel Med Tech connects twiist insulin pump to Abbott's CGM ahead of market debut
Greenlighted for people ages 6 and older with Type 1 diabetes, Sequel’s twiist system is slated to begin its commercial launch by the end of June.
Read More

Tags:

Previous Article

The biggest machine in science: inside the fight to build the next giant particl...

Next Article

Zelestra secures 220MW/1GWh solar-plus-storage PPA in Chile

Related Posts

Immunovant won't seek approval for autoimmune drug despite phase 3 win

Immunovant won't seek approval for autoimmune drug desp...

Mar 19, 2025  0

Cryoablation developer Adagio Medical lays off staff, refocuses on US study

Cryoablation developer Adagio Medical lays off staff, r...

Feb 28, 2025  0

Pfizer to test Summit’s white-hot bispecific with ADCs

Pfizer to test Summit’s white-hot bispecific with ADCs

Feb 24, 2025  0